536,000 Shares in Tilray Brands, Inc. $TLRY Acquired by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. bought a new position in Tilray Brands, Inc. (NASDAQ:TLRY) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 536,000 shares of the company’s stock, valued at approximately $4,855,000. Hillsdale Investment Management Inc. owned about 0.46% of Tilray Brands as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. Oppenheimer & Co. Inc. purchased a new position in Tilray Brands in the third quarter valued at approximately $25,000. Y Intercept Hong Kong Ltd purchased a new position in Tilray Brands in the third quarter valued at approximately $30,000. HighPoint Advisor Group LLC purchased a new position in Tilray Brands in the third quarter valued at approximately $33,000. Clearstead Advisors LLC raised its holdings in Tilray Brands by 437.3% in the third quarter. Clearstead Advisors LLC now owns 21,625 shares of the company’s stock valued at $37,000 after buying an additional 17,600 shares during the period. Finally, Insigneo Advisory Services LLC purchased a new position in Tilray Brands in the third quarter valued at approximately $46,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Wall Street Analyst Weigh In

TLRY has been the topic of several research reports. Zacks Research upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. ATB Cormark Capital Markets cut their price target on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a report on Thursday, April 2nd. Wall Street Zen upgraded shares of Tilray Brands from a “sell” rating to a “hold” rating in a report on Saturday, March 21st. TD Cowen cut their price target on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Monday, March 30th. Finally, Roth Mkm upgraded shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Thursday, April 2nd. Three analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Tilray Brands presently has a consensus rating of “Hold” and a consensus price target of $11.50.

Insider Activity

In other news, Director David G. Hopkinson sold 33,556 shares of Tilray Brands stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total transaction of $232,878.64. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.84% of the stock is owned by corporate insiders.

Tilray Brands Trading Down 2.5%

TLRY opened at $5.51 on Friday. The firm has a market capitalization of $642.19 million, a P/E ratio of -0.40 and a beta of 1.94. The firm’s 50 day moving average is $6.20 and its 200-day moving average is $7.91. Tilray Brands, Inc. has a 52-week low of $3.51 and a 52-week high of $23.20. The company has a quick ratio of 1.66, a current ratio of 2.79 and a debt-to-equity ratio of 0.19.

Tilray Brands (NASDAQ:TLRY) last posted its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). The firm had revenue of $206.73 million for the quarter, compared to analysts’ expectations of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same quarter in the prior year, the business earned ($0.87) EPS. Analysts expect that Tilray Brands, Inc. will post -0.58 EPS for the current fiscal year.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.